$PLUR

Pluri Inc.

Pluri is a biotechnology company headquartered in Haifa, Israel. It develops, manufactures and commercializes cell-based products, therapeutics and related technologies using a proprietary 3D cell expansion platform and an in-house cell manufacturing facility. Its activities span Human Health and Longevity and Foodtech and Bio-Farming. In human health, Pluri develops placenta-based cell therapy and immunotherapy candidates, offers cell therapy development and manufacturing services through PluriCDMO™, and develops skincare, haircare and aesthetic products through Cellav™. In Foodtech and Bio-Farming, Pluri’s initiatives include plant-cell coffee development through Coffeesai, cell-cultured cacao through its majority-owned Kokomodo subsidiary, agricultural collaborations, and cultivated meat technology through Ever After Foods. Pluri makes money through development and manufacturing services for pharmaceutical and biotechnology companies, and through commercialization of its products and technologies. Ever After Foods develops a business-to-business platform for food producers, while Cellav markets products and ingredients for professional and consumer use.

1
0
0
$1.3M
—
Manieu Alexandre Weinstein
0%
See all $PLUR insider activity →
Low

Plurilock Security Inc. (PLUR) ISS Recommends Vote for Quantum eMotion Deal

ISS recommends Plurilock shareholders vote for Quantum eMotion's acquisition, offering $0.084 cash and 0.0763 QeM shares per share. The shareholder meeting is set for November 18, 2026, with a proxy deadline of November 16, 2026. Shareholders can contact Laurel Hill Advisory Group for assistance.

Zeo ScientifiX and Pluri Forge U.S. Partnership, Giving Pluri 50% Ownership

Zeo ScientifiX and Pluri agreed to a partnership for U.S. manufacturing and commercialization of regenerative medicine products. Pluri will own 50% of Zeo ScientifiX's shares and receive preferred shares and warrants. Zeo ScientifiX gains an exclusive U.S. license to Pluri's portfolio, with royalties based on net sales. Closing is expected in Q4 2026, subject to conditions.

Pluri Inc. (PLUR): Entry into a Material Definitive Agreement

Pluri Inc. (PLUR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. ZEO Partnership Agreement On October 26, 2026, Pluri Inc. (“Pluri” or the “Company”) entered into a Partnership Agreement (the “Agreement”) with ZEO ScientifiX, Inc. (“ZEO”) pursuant to which, at the closing of the transaction

PLUR sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning PLUR (Pluri Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent PLUR coverage spans corporate actions, mergers & acquisitions and earnings.

In the last 30 days, PLUR insiders filed 1 SEC Form 4 transaction — 1 purchase ($1.3M) and no sales. The most active reporter was Manieu Alexandre Weinstein with 1 filing.

What's driving PLUR

  • The acquisition proposal introduces new mixed consideration terms, likely influencing PLUR's share price ahead of the shareholder vote.

    tradingview.com · Nov 3, 2026

  • Zeo ScientifiX and Pluri agreed to a partnership for U.S. manufacturing and commercialization of regenerative medicine products. Pluri will own 50% of Zeo ScientifiX's shares and receive preferred shares and warrants. Zeo ScientifiX gains an exclusive U.S. license to Pluri's portfolio, with royalties based on net sales. Closing is expected in Q4 2026, subject to conditions.

    tradingview.com · Oct 30, 2026

  • The agreement gives Pluri a large equity position in ZEO and potential revenue from the licensed portfolio.

    SEC EDGAR 8-K · Oct 30, 2026

  • Strategic partnership adds growth potential.

    rttnews.com · Oct 27, 2026

  • Insider purchase suggests confidence in Pluri, but the transaction size is modest relative to market cap.

    SEC EDGAR · Oct 27, 2026

AlphAI scores every news story that mentions PLUR with an AI model for sentiment and relevance, and aggregates insider trades from Pluri Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PLUR

Score

Zeo ScientifiX and Pluri Forge U.S. Partnership, Giving Pluri 50% Ownership

Zeo ScientifiX and Pluri agreed to a partnership for U.S. manufacturing and commercialization of regenerative medicine products. Pluri will own 50% of Zeo ScientifiX's shares and receive preferred shares and warrants. Zeo ScientifiX gains an exclusive U.S. license to Pluri's portfolio, with royalties based on net sales. Closing is expected in Q4 2026, subject to conditions.

$PLURMedContract· supplier

Pluri Inc. (PLUR): Entry into a Material Definitive Agreement

Pluri Inc. (PLUR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. ZEO Partnership Agreement On October 26, 2026, Pluri Inc. (“Pluri” or the “Company”) entered into a Partnership Agreement (the “Agreement”) with ZEO ScientifiX, Inc. (“ZEO”) pursuant to which, at the closing of the transaction

$PLURLowOffering· $1.25M · priced

Pluri Inc. (PLUR): Entry into a Material Definitive Agreement

Pluri Inc. (PLUR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on June 14, 2026, Pluri Inc. (the “Company”) entered into an advance subscription agreement with Chutzpah Holdings LP (the “Purchaser”), a limited partnership beneficially owned by Mr. Alexandre Weinst

$PLURMedOffering· $2.98M · proposed

Pluri Inc. (PLUR): Entry into a Material Definitive Agreement

Pluri Inc. (PLUR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 26, 2026, Pluri Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Purchaser”) pursuant to which the Company agreed to issue and s

$PLURMedM&A· acquirer · $2M · definitive

Ever After Foods Ltd., an indirect majority-owned subsidiary of Pluri Inc., entered into a share purchase agreement with Fishway BV and the holders of…

Pluri Inc. (PLUR) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On August 12, 2026, Ever After Foods Ltd. (“EAF”), an indirect majority-owned subsidiary of Pluri Inc. (the “Company”), entered into a share purchase agreement (the “Share Purchase Agreement”) with Fishway BV (“Fishway”) and the holders of certain securiti

Related tickers